Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides (Q43704020)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Fukunaga Y

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Itoh H

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Doi K

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Tanaka T

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Yamashita J

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Chun TH

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Inoue M

7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Masatsugu K

8

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sawada N

9

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Saito T

10

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Hosoda K

11

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Kook H

12

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Ueda M

13

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Nakao K

14

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

1 September 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

158

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

113-119

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Down regulation of peroxisome proliferator-activated receptorgamma expression by inflammatory cytokines and its reversal by thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

C-type natriuretic peptide in human coronary atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system"

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Vascular natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells: A possible role for PPARgamma in endothelial function.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

PPARgamma agonists enhance human vascular endothelial adhesiveness by increasing ICAM-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Troglitazone-induced fulminant hepatic failure. Acute Liver Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARgamma on vascular endothelial function.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Regulation of endothelial production of C-type natriuretic peptide in coculture with vascular smooth muscle cells. Role of the vascular natriuretic peptide system in vascular growth inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Increasing insulin sensitivity lowers blood pressure in the fructose-fed rat

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900430-0

7 January 2021

Identifiers

10.1016/S0021-9150(01)00430-0

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43704020&oldid=2164758729"